The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASE I F COD FOLL SEQ IMAGE EVENT DT MFR DT FDA DT REPT COD MFR NUM MFR SNDR AGE AGE COD GNDR COD E SUB WT WT COD REPT DT OCCP COD DEATH DT TO MFR CONFID REPORTER COUNTRY
8016634 8317520 I 8016634-1 20111220 20111231 EXP PHHY2011JP111352 SANDOZ,INC. 32 YR F Y 20111231 OT JAPAN

Drug(s) used by person

Event ID DRUG SEQ ROLE COD DRUGNAME VAL VBM ROUTE DOSE VBM DECHAL RECHAL LOT NUM EXP DT NDA NUM
8016634 1018419943 SS HYDRALAZINE HYDROCHLORIDE 1 INTRAVENOUS 6 MG, UNK
8016634 1018419941 SS CYCLOSPORINE 1 ORAL 60 MG, UNK
8016634 1018419942 PS HYDRALAZINE HYDROCHLORIDE 1 083241
8016634 1018419944 C PREDNISOLONE 1 ORAL

Indications of drugs used

Event ID DRUG SEQ INDI PT
8016634 1018419941 APLASTIC ANAEMIA
8016634 1018419944 APLASTIC ANAEMIA

Outcome of event

Event ID OUTC COD
8016634 HO

Reactions reported

Event ID PT
8016634 GESTATIONAL HYPERTENSION
8016634 MATERNAL EXPOSURE DURING PREGNANCY

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found